# Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy

> **NCT01960621** · PHASE4 · WITHDRAWN · sponsor: **Imperial College London**

## Conditions studied

- Cough

## Interventions

- **DRUG:** cyclodextrin

## Key facts

- **NCT ID:** NCT01960621
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2017-08
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study has not been able to start due to difficulty in obtaining an intravenous formulation of cyclodextrin (intravenous 2HPBCD) suitable for man
- **Last updated:** 2019-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01960621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01960621, "Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01960621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*